Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Important safety information Dual GIP/GLP-1 Weekly compounded injection with a dual GIP and GLP-1 receptor agonist that may support appetite control.* Important safety information Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA
Lowering your dose may temporarily reduce thirst, but it may also reduce the medication's weight-loss efficacy
Sleep disturbances are not typically the most common side effects associated with GLP-1 receptor agonists, including Semaglutide
Temperature Control Compounded semaglutide must be kept in the refrigerator
Participants are also encouraged to report suspected side effects directly via the MHRA Yellow Card Scheme at yellowcard.[18]mhra.gov.uk, in addition to notifying their trial team
Participants in the trials struggled with obesity but had no known serious mental health disorders when they started the trial, and they were either given semaglutide or a placebo over 68 weeks
US$ 25.81
US$ 25.19
US$ 22.13
US$ 24.42
US$ 29.12
US$ 22.59
US$ 25.47
US$ 25.84
